Pathologic fracture and metastatic spinal cord compression in patients with prostate cancer and bone metastasesReportar como inadecuado

Pathologic fracture and metastatic spinal cord compression in patients with prostate cancer and bone metastases - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

BMC Urology

, 10:23

First Online: 22 December 2010Received: 02 December 2009Accepted: 22 December 2010


BackgroundThe purpose of this study was to determine the risk factors for and incidence as well as prognostic impact of pathologic fracture PF and metastatic spinal cord compression MSCC in patients with bone metastases BM from prostate cancer.

MethodsRetrospective cohort study including 61 consecutive patients seen at Nordland hospital-s department of oncology between 2007 and 2009. The initial diagnosis of BM might have been made earlier. Twenty-nine patients 48% received taxotere and 72% zoledronic acid after diagnosis of BM.

ResultsMedian actuarial survival after diagnosis of BM was 23 months. Six patients 10% were alive at 5 years. Bone pain at baseline was present in 49% of patients. Eighty-nine percent required external beam radiotherapy and-or radioisotopes after diagnosis of BM. Seventeen patients 28% developed at least one major skeletal complication, i.e. MSCC or PF 4 of them developed more than one. The actuarial risk was 44% at 4 and 5 years. Most events developed before treatment with zoledronic acid and-or taxotere. Median survival from diagnosis of either MSCC or PF was 11 months 5 months from MSCC. We did not identify statistically significant risk factors for development of major skeletal complications. Serum alkaline phosphatase above median value and age less than or equal to 70 years were the only risk factors approaching significance.

ConclusionsWe found high rates of major skeletal complications in this unselected contemporary group of patients. Identification of risk factors might guide the development of early interventions aiming at prevention of MSCC and PF.

Electronic supplementary materialThe online version of this article doi:10.1186-1471-2490-10-23 contains supplementary material, which is available to authorized users.

Download fulltext PDF

Autor: Carsten Nieder - Ellinor Haukland - Adam Pawinski - Astrid Dalhaug


Documentos relacionados